6Gao F.Chen J,Lo Pez BL,et al.Comparison of bisoprolol and carwedilol cardioprotetection in a rabbit ischemia and model[J].Eur J Pharmacol,2000,406(2):109-116.
3Anonymous.Consensus recommendations for the management of chronic heart failure On behalf of the membership of the advisory council to im prove outcomes nationwide in heart failure[J].Am J Cardiol,1999,83:138.
4Struthers AD.Aldostorone escape during ACE inihibitor therapy in chronic heart failure[J].Eur Heart J,1995,16:N103-106.
5Bristow MR.Carvediol treatment of chronic heart failure:a newer[J].Heart,1998,79:8.
6Stoschitz KY,Koshucharova,Zweiker R,et al.Differing beta-blocking effects of carvedilol and metoprolol[J].Heart Failure,2001,3:343-349.
7Cargnoni A,Ceconic,Bemocchi P,et al.Reduction of oxidative stress by carvedilol:role in maintenance of ischaemic myocardium viability[J].Cardil-Vasc Res,2000,47:556-556.
8Bristow MR.Mechanism of action of beta blocking agents in heart failure[J].Am J Cardiol,1997,80:26-40.
9Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
1Constant J. A review of why and how we may use beta-blockers in congestive heart failure[J].Chest, 1998,113 (3) : 800-808.
2Di Lenarda A,Sabbadini G,Salvatore L,et al. Long-term effects of carvediol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group [J].J Am Coil Cardiol, 2000,33(7) :1926-1934.
3Matsumura T, Tsushima K, Ohtaki E, et al. Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy [J]. J Cardiol, 2002,39(5): 2S:3-257.
4Khattar RS, Senior R, Soman P, et aI. Regression of left ventricular remodeling in chronic heart failure:Comparative and combined effects of captopril and carvedilol [J]. Am Heart J, 2001,142(2):704 713.
5Packer M, B rlstow MR, Cohn IN, et al. Effect of carvedilol on morbidity and mortality in patients with chronic heart failure[ J]. N Engl J Med, 1996,334 : 1349.
6Kourea K,Paxlssfs JT,Fannakis D,et al. Effects of darbepoetin- al- pha on plasma prointlammatory cytokines, antiinflammatory cytokine interleukin - 10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure[J]. Atherosclerosls ,2008,199(1 ) :215 -221.
7Whorlow SL, Krun H. Meta - analysis of effect of 13 - blocker therapy on mortality in patients with New York Heart Association class TV chronic congestive heart failure[J] .Am J Cardlol,2000,86 :886 -889.
